TGFB1 and bladder transitional cell carcinoma: Inhibiting EMT, including the suppression of mesenchymal marker N-calmodulin and EMT-related pathways such as TGF-β and Wnt/β-catenin, has been shown to significantly impede the EMT process, leading to substantial inhibition of BLCA invasion and metastasis [47].